CARPINTERIA, Calif.--(BUSINESS WIRE)--Through collaborative efforts with multiple industry partners, Celerus Diagnostics has successfully demonstrated Rapid ISH™ (in-situ hybridization) on its forthcoming Wave RPD System. In-situ hybridization uses a labeled complementary DNA or RNA strand to localize a specific sequence in a section of tissue. This is distinct from immunohistochemistry which localizes proteins in tissue sections.
